Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar;105(10):181-7.
doi: 10.3238/arztebl.2008.0181. Epub 2008 Mar 7.

Current diagnosis and treatment of spondylodiscitis

Affiliations

Current diagnosis and treatment of spondylodiscitis

Rolf Sobottke et al. Dtsch Arztebl Int. 2008 Mar.

Abstract

Introduction: Infection of the spinal column is rare, and often recognized and treated too late. Spondylodiscitis is osteomyelitis of the spine and can cause severe symptoms. Hospital mortality is in the region of 2% to 17%.

Methods: Selective literature review and results of the authors' own research.

Results: The incidence of pyogenic spondylodiscitis is around 1 : 250 000, which represents around 3% to 5% of osteomyelitis as a whole. 10% to 15% of all vertebral infections can be ascribed to exogenous spondylodiscitis, with Staphylococcus aureus as the commonest pathogen, 2% to 16% of which are reported to be MRSA (methicillin-resistant S. aureus). Catheter-related, nosocomial infection with MRSA is a key cause for spondylodiscitis. 50% of all skeletal tuberculoses are found in the spine.

Discussion: Spondylodiscitis should be borne in mind in cases of diffuse back pain and non-specific symptoms. MRI is the diagnostic modality of choice for detecting spondylodiscitis. Thanks to precise monitoring of conservative treatments and primarily stable surgical techniques, prolonged immobilization of the patient is no longer necessary nowadays.

Keywords: spinal infection; spine; spondylitis; spondylodiscitis; vertebral osteomyelitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MRI: sagittal and axial cross-sections: T1 and contrast medium in a patient with specific spondylitis (atypical mycobacteria: Mycobacterium xenopi) at the level of thoracic vertebral body 10
Figure 2
Figure 2
Fluorine-18 fluorodeoxyglucose PET (FDG PET) shows marked excess enrichment over several segments (circa thoracic vertebral bodies 9 to 12), with a standard uptake value (SUV max) of 9.1.
Figure 3
Figure 3
Algorithm for the intraoperative removal of tissue samples
Figure 4
Figure 4
Cervical non-specific spondylodiscitis in cervical vertebral bodies 3/4 and postoperative native radiological follow-up with properly positioned bone span and plate
Figure 5
Figure 5
Three month postoperative native radiological follow-up after bilateral dorsoventral spondylodesis of thoracic vertebral bodies 2 and 3
Figure 6
Figure 6
CT in recurrent spondylodiscitis one year after dorsoventral fusion

References

    1. Cramer J, Haase N, Behre I, Ostermann PAW. Spondylitis und Spondylodiszitis. Trauma und Berufskrankheit. 2003;5:336–341.
    1. Eysel P, Hopf C, Meurer A. Korrektur und Stabilisierung der infektbedingten Wirbelsäulendeformität. Orthopädische Praxis. 1994;11:696–703.
    1. Frangen TM, Kälicke T, Gottwald M, et al. Die operative Therapie der Spondylodiszitis. Eine Analyse von 78 Patienten. Der Unfallchirurg. 2006;109:743–753. - PubMed
    1. Klöckner C, Valencia R, Weber U. Die Einstellung des sagittalen Profils nach operativer Therapie der unspezifischen destruierenden Spondylodiszitis: ventrales oder ventrodorsales Vorgehen - ein Ergebnisvergleich. Orthopäde. 2001;30:965–967. - PubMed
    1. Eysel P, Peters KM. Spondylodiszitis. In: Peters KM, Klosterhalfen B, editors. Bakterielle Infektionen der Knochen und Gelenke. Stuttgart: Enke; 1997. pp. 52–93.